Back to All News
3Billion News
AI in Healthcare3 articles
Latest news, updates, and announcements from 3Billion.
FundingSep 22, 2026
3Billion moves from rare-disease diagnostics into therapeutic development under a national research grant.
3Billion (쓰리빌리언), the Seoul-based AI genetic-diagnostics company for rare diseases led by CEO Chang-Won Kum, has been selected as a joint research institution under Korea's ARPA-H-style "ARISE" progra...
ExpansionAug 17, 2026
3Billion (쓰리빌리언), a South Korean AI genetic diagnostics firm, has secured a contract to perform whol...
3Billion (쓰리빌리언), a South Korean AI genetic diagnostics firm, has secured a contract to perform whole-genome sequencing (WGS)-based newborn screening for 1,800 cases under the Korean Genome Newborn Sc...
FundingApr 23, 2026
3billion Secures 30 Billion KRW to Scale AI-Driven Genetic Diagnostics in U.S. Market
AI-based rare disease diagnostic company 3billion has raised 30 billion KRW through a hybrid financing structure consisting of 17.5 billion KRW in convertible preferred shares (CPS) and 12.5 billion K...